Pfizer Recalls Pristiq
July 3, 2014 - Pfizer issued a voluntary recall of Pristiq (desvenlafaxine). The recall is due to a 100 mg tablet of Pristiq Extended Release found in a 50 mg bottle.
Pristiq is a serotonin and norepinephrine reuptake inhibitor (SNRI) used to treat depression.
The Pristiq recall covers 4 lots of 50mg bottles which extend to 220,761 bottles with the NDC 000-8-1211-30.
Benecard Central Fill has not dispensed any recalled lots of Pristiq.
Adverse reactions or quality problems experienced with the use of a recalled product may be reported to the FDA’s MedWatch Adverse Event Reporting Program either online, by regular mail or by fax.
- Complete and submit the report Online: www.fda.gov/medwatch/report.htm
- Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178
Actual drug patent expiration dates and availability of new medications are subject to change due to patent litigation, settlement agreements, additional patents, exclusivities, and final FDA approval. Distribution and availability of new medications at pharmacies may not occur immediately following FDA approval. Patients are advised to speak with their healthcare professional or pharmacist regarding appropriateness as well as actual availability.
*This is provided for information only. The reference to any medication above does not mean the medication is covered by your plan.